Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii

Publication Work Type

Article

more of publication

Genomic and epidemiological insights into the emergence and dominance of MRSA clones in Riyadh’s healthcare facilities

by 3- Alkuraythi, D.M.; Alkhulaifi, M.M.; Altwiley, D.A.; Alarwi, M.; Mujallad, M.I.; Alshomrani, M.K.; Gojobori, T.; Alajel, S.M.

2026

Published in:

Scientific Reports

Genomic Characterization and Resistance Mechanisms of Carbapenem-Resistant Klebsiella pneumoniae ST101 Isolates from Saudi Arabia

by 4- Idrees, E.K.; Alkhulaifi, M.M.; Aldriwesh, M.G.; Alqurainy, N.; Okdah, L.; Alswaji, A.A.; Alrashidi, E.T.; Alshahrani, A.S.; Al Johani, S.M.; MNGHA Surveillance Group; et al.

2025

Published in:

MDPI

High-resolution genomic and molecular characterization of vancomycin-resistant enterococci from hospitalized patients in a tertiary care center in Riyadh, Saudi Arabia. Scientific Reports.

by 5- Latifah D.Almasaud, Manal M.Alkhulaifi, Akela Ghazawi, Nikolaos Strepis, Ashrat Manzoor, Abiola Senok, Hisham H.Alajlan, Mohammed S. Almogbel, Danesh Moradigaravand & Mushtaq Khan.

2025

Published in:

Scientific Reports

منال بنت محمد ابراهيم الخليفي --Manal Mohammed al khulaifi

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii